Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated with radiotherapy combined or not with androgen deprivation therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of oncology 2010-04, Vol.21 (4), p.903-904
1. Verfasser:	Heyns, C.F.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - blood Adenocarcinoma - diagnosis Adenocarcinoma - drug therapy Adenocarcinoma - radiotherapy Androgen Antagonists - therapeutic use Antineoplastic Agents, Hormonal - therapeutic use Combined Modality Therapy Down-Regulation Early Diagnosis Humans Male Prognosis Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - drug therapy Prostatic Neoplasms - radiotherapy Radiotherapy Dosage Survival Analysis Time Factors Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!